Purpose: As a result of a partnership between the Office of Rare Diseases (ORD) and the National Institute of Neurological Disorders and Stroke, we are requesting target nominations for the production of monoclonal antibodies that would be useful for basic and clinical research of rare diseases. Targets involved in all the rare diseases are eligible for consideration.
Last updated December 15, 2008